Phase II study of neoadjuvant therapy with epirubicin and docetaxel for women with locally advanced breast cancer.

被引：0
|
作者：
Holter, JL
Tfayli, A
Venkattapa, S
Bova, A
Howard, O
机构：
[1] Univ Oklahoma, Moore, OK USA
[2] Univ Oklahoma, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：98S / 98S
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) chemotherapy followed by docetaxel in refractory patients with locally advanced breast cancer.
    Heller, W.
    Mazhar, D.
    Ward, R.
    Lowdell, C.
    Dudley, S.
    Sami, S.
    Carlo, P.
    Charles, C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S157 - S157
  • [42] Phase II trial of neoadjuvant docetaxel and carboplatin with filgrastim (G-CSF) support in patients with locally advanced breast cancer.
    Karmarkar, S
    Jones, D
    Hatch, S
    Klementich, F
    Ansari, K
    Grube, B
    Chao, C
    Townsend, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 74S - 74S
  • [43] Phase II study of neoadjuvant Docetaxel (T) Doxorubicin (A) and Capecitabine (X) treatment in locally advanced or inflammatory breast cancer. Goti Cooperative Study Group
    Isabel Palomero, Ma
    Belon, Joaquin
    Quiben, Rosa
    Perez-Manga, Gumersindo
    ANNALS OF ONCOLOGY, 2004, 15 : 33 - 33
  • [44] Phase II study of dose-dense docetaxel (T) and epirubicin (E) as neoadjuvant treatment for locally advanced breast cancer (LABC).: An ONCOPAZ Cooperative Group
    Lorenzo, A
    Madroñal, C
    Sanz, JJ
    Centelles, M
    López, MR
    Casas, A
    Péez, VG
    de la Puente, CG
    López, MJG
    Borrega, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 72S - 72S
  • [45] Epirubicin and Docetaxel as Primary Chemotherapy in Locally Advanced Breast Cancer
    Conti, F.
    Corsetti, S.
    Viola, G.
    Sperduti, I.
    Carpano, S.
    Pizzuti, L.
    Foggi, P.
    Perri, P.
    Anza, M.
    Toglia, G.
    Lopez, M.
    ONCOLOGY, 2009, 77 : 139 - 140
  • [46] Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study
    Nielsen, D
    Dombernowsky, P
    Larsen, SK
    Hansen, OP
    Skovsgaard, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (06) : 459 - 466
  • [47] Epirubicin or epirubicin and cisplatin as first-line therapy in advanced breast cancer. A phase III study
    Dorte Nielsen
    Per Dombernowsky
    Susanne Kornum Larsen
    Ole Paaske Hansen
    Torben Skovsgaard
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 459 - 466
  • [48] Predictors of response to neoadjuvant chemotherapy in women with locally advanced breast cancer.
    Parmar, V
    Nadkarni, M. S.
    Hawaldar, R.
    Shet, T.
    Nair, R.
    Gupta, S.
    Chinoy, R.
    Badwe, R.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S172 - S173
  • [49] Neoadjuvant chemotherapy in locally advanced breast cancer.
    Soraya, Sami Sahnoun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer
    Tuxen, Malgorzata K.
    Cold, Soeren
    Tange, Ulla B.
    Balslev, Eva
    Nielsen, Dorte L.
    ACTA ONCOLOGICA, 2014, 53 (10) : 1440 - 1445
12345